Cargando…
Revisiting myocardial necrosis biomarkers: assessment of the effect of conditioning therapies on infarct size by kinetic modelling
Infarct size is a major predictor of subsequent cardiovascular events following ST-segment elevation myocardial infarction (STEMI) and is frequently used in clinical trials focused on cardioprotection. Approximately assessed through serial blood sampling, it can be accurately measured by imaging tec...
Autores principales: | Ternant, David, Ivanes, Fabrice, Prunier, Fabrice, Mewton, Nathan, Bejan-Angoulvant, Theodora, Paintaud, Gilles, Ovize, Michel, Angoulvant, Denis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587689/ https://www.ncbi.nlm.nih.gov/pubmed/28878319 http://dx.doi.org/10.1038/s41598-017-11352-4 |
Ejemplares similares
-
Kinetic modelling of myocardial necrosis biomarkers offers an easier, reliable and more acceptable assessment of infarct size
por: Chadet, Stéphanie, et al.
Publicado: (2020) -
Influence of cardiovascular risk factors on infarct size and interaction with mechanical ischaemic postconditioning in ST-elevation myocardial infarction
por: Pichot, Sophie, et al.
Publicado: (2015) -
Infliximab Efficacy May Be Linked to Full TNF-α Blockade in Peripheral Compartment—A Double Central-Peripheral Target-Mediated Drug Disposition (TMDD) Model
por: Ternant, David, et al.
Publicado: (2021) -
Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction
por: Mewton, Nathan, et al.
Publicado: (2021) -
Anti-Inflammatory Drug Candidates for Prevention and Treatment of Cardiovascular Diseases
por: Delbaere, Quentin, et al.
Publicado: (2023)